Alexza Pharmaceuticals, Inc. (ALXA) Posts Q2 EPS Loss of $0.13
Tweet
Share
E-mailGet Alerts ALXA Hot Sheet
Price: $0.92 --0%
Financial Fact:
Total operating expenses: 10.66M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Total operating expenses: 10.66M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) reported Q2 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $1.26 million versus the consensus estimate of $430 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
- Taylor Devices (TAYD) Misses Q4 EPS by 31c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
